Oncorus Overview
- Founded
- 2015

- Status
- Public
- Employees
- 51

- Stock Symbol
- ONCR

- Share Price
- $14.11
- (As of Friday Closing)
Oncorus General Information
Description
Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients. The company is in the process of developing intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors.
Contact Information
- 50 Hampshire Street
- Suite 401
- Cambridge, MA 02139
- United States
Oncorus Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$14.11 | $13.91 | $13.05 - $37.86 | $361M | 25.6M | 152K | -$5.08 |
Oncorus Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
---|---|---|---|
Revenue | 0 | 0 | 0 |
EBITDA | (44,647) | (30,142) | (17,318) |
Net Income | (45,599) | (30,704) | (18,046) |
Total Assets | 62,059 | 50,826 | 25,656 |
Total Debt | 0 | 0 | 0 |
Oncorus Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Oncorus‘s full profile, request access.
Request a free trialOncorus Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
This information is available in the PitchBook Platform. To explore Oncorus‘s full profile, request access.
Request a free trialOncorus Comparisons
Industry
00000 00
00000 00
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialOncorus Competitors (55)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Sesen Bio | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
00000 000000000000 | Formerly VC-backed | Watertown, MA | 00 | 00.000 | 00000000 | 00.000 |
0000000 | Venture Capital-Backed | San Diego, CA | 00 | 00.000 | 0000000000 0 | 00.000 |
0000000 | Venture Capital-Backed | Houston, TX | 00 | 000.00 | 000000000 - | 000.00 |
00000 | Private Equity-Backed | San Diego, CA | 00 | 00000 | 0000000 0000 | 00000 |
Oncorus Executive Team (10)
Oncorus Board Members (12)
Name | Representing | Role | Since |
---|---|---|---|
Alon Lazarus Ph.D | Self | Board Member | 000 0000 |
Briggs Morrison MD | MPM Capital | Board Member | 000 0000 |
Cameron Wheeler Ph.D | Deerfield Management | Board Member | 000 0000 |
Luke Evnin Ph.D | MPM Capital | Board Member | 000 0000 |
Mary Fenton | Oncorus | Board Member | 000 0000 |
Oncorus Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialOncorus Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Oncorus‘s full profile, request access.
Request a free trial